Viewing Study NCT02332850


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-28 @ 8:17 AM
Study NCT ID: NCT02332850
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-01
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma
Sponsor: Thomas Martin, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module